A planned $1.2 billion beauty empire has significantly downsized, with Waldencast Acquisition Corp. selling off Obagi Medical and focusing solely on the struggling Milk Makeup brand. Milk Makeup has experienced a dramatic sales decline of 57.1% in the first half of 2026, resulting in a substantial adjusted EBITDA loss. In response to these financial challenges, Waldencast is delisting from Nasdaq and plans to trade on an over-the-counter market to reduce operational costs. AI
RANK_REASON Company is delisting from a major exchange and focusing on a single struggling brand, indicating a significant business downturn rather than a core AI development.
- Bridgepoint Group plc
- Hind Sebti
- L'Oréal
- Michel Brousset
- Milk Makeup
- Nasdaq
- Obagi Medical
- Rohto Pharmaceutical Co., Ltd.
- Sephora
- Ulta Beauty
- Waldencast Acquisition Corp.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →